Business
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
HIMSS25
AI tools can personalize patients' searches for providers, but Kyruus Health's Gen Conlin believes nurse informaticists' ability to ensure tool accessibility and accuracy are vital to ensuring patients find the right care.
HIMSS25
With healthcare spending, particularly for Medicare Advantage, under scrutiny, 1upHealth's Dr. Don Rucker says AI-ready, open API platforms that can integrate and analyze disparate data are needed to inform care and control costs.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
In response to a new price cap law in Indiana, Hal Andrews, CEO of Trilliant Health, says once a state legislature is allowed to determine maximum reimbursement, hospitals are subject to that being changed any time the legislature gets together.
HIMSS25
Edward Marx, CEO of Marx Advisory, recommends that healthcare leaders looking to drive innovation in their organizations become innovative themselves by bringing their C-suite to meet with and learn from partners.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
Anne Osdoit, CEO of Moon Surgical, discusses the company’s Maestro surgical robotics system and how it supports surgeons during soft tissue procedures.